Australian TGA Approves Illuccix® for Prostate Cancer Imaging

Go back to Australian TGA Approves Illuccix® for Prostate Cancer Imaging
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.97 --0 (-0%)
Previous Close $11.97    52 Week High $2.18 
Open $11.97    52 Week Low $0.30 
Day High $11.97    P/E N/A 
Day Low $11.97    EPS $-3.32 
Volume 624